Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (871)	6/27/1997 6:23:00 PM
From: BadMan	of 6136

Peter, I could not agree with you more. But Davids' strong point of the life expectancy of a drug shall not only apply to Viracept, but to all new drugs in general. With the technological advances today, no one can predict how effective a drug will be five to ten years from now. This is why I search for companies with outstanding product pipelines. IMO, PIs will take us to the next generation of medicine for treating diseases. Just review how many PIs ( a ton) are currently under development. But remember, AGPH owns almost have of all issued PI patents. BadMan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next